Adepal is a second-generation biphasic contraceptive pill that combines ethinylestradiol and levonorgestrel. This progestin has a neutral to slightly androgenic profile, which clearly distinguishes it from anti-androgen molecules used in pills prescribed for acne. Understanding this pharmacological difference helps to clarify what can be reasonably expected from Adepal regarding skin lesions.
Levonorgestrel and Acne: Why Adepal is Not an Anti-Androgen Pill
Sebum is produced under the influence of androgens. Pills that significantly improve acne contain progestins with marked anti-androgenic activity: cyproterone acetate, drospirenone, chlormadinone. These molecules directly inhibit the stimulation of sebaceous glands.
Recommended read : Tips and Advice for Peacefully Navigating Parenthood with Twins
The levonorgestrel present in Adepal does not have this property. Its action on the skin remains indirect: the estrogenic component (ethinylestradiol) increases the production of SHBG, a protein that captures some of the circulating androgens. The result on acne, when it exists, remains modest and varies from one patient to another.
To complement this analysis, a review of the Adepal pill details the feedback observed on the skin after several months of use. The distinction between a benefit related to estrogen and a true anti-acne effect of the progestin changes the interpretation of online testimonials.
Related reading : Our tips for reading hentai online discreetly and safely
Adepal and Acne Treatment: What Current Protocols Recommend
Acne management strategies place topical treatments (benzoyl peroxide, topical retinoids) and, in some cases, short antibiotics as first-line options. Oral isotretinoin is reserved for severe or resistant forms.
The contraceptive pill only comes into play in this scheme when the patient already desires contraception. Recent recommendations emphasize this point: the pill should not be prescribed solely for the purpose of treating acne.
Adepal, with its progestin lacking direct anti-androgenic effect, is now considered a low priority for patients whose main complaint is acne. Pills containing drospirenone or chlormadinone offer a clearer skin benefit, documented in official indications.
Microcystic Acne and the Limitations of Adepal
Microcystic or very resistant acne responds poorly to a neutral progestin. Levonorgestrel may, in some women, maintain a slight androgenic stimulation that keeps seborrhea ongoing. This profile explains the contradictory testimonials: some users report improvement related to estrogen, while others notice no change or even worsening.
Stopping Adepal and Acne Rebound: An Underestimated Risk
Any combined pill suppresses ovarian androgen production during use. Upon stopping, this production resumes, and seborrhea can return abruptly. This phenomenon, known as acne rebound, affects a notable proportion of women, regardless of the pill used.
Several recent reviews emphasize the need to prepare for the cessation of hormonal contraception. Adjusting skincare routines and, if necessary, initiating a non-hormonal topical or oral treatment before stopping the pill reduces the intensity of the rebound.
- Introduce a topical retinoid or benzoyl peroxide a few weeks before stopping to stabilize the skin.
- Consult a dermatologist if acne was severe before starting the pill, to anticipate a possible resumption of treatment.
- Monitor symptoms over several cycles, as rebound can appear with a delay of two to three months after stopping.
Choosing Between Adepal and an Anti-Acne Pill: Decision Criteria
The choice of oral contraception depends on several factors that go beyond just skin concerns. Adepal has an advantage: its second-generation profile is associated with a lower thromboembolic risk than that of third or fourth-generation pills containing anti-androgen progestins.
For a woman with mild acne who primarily seeks reliable contraception, Adepal may suffice. The estrogenic component provides a partial skin benefit suitable for moderately oily skin.
However, for moderate to severe, persistent, or inflammatory acne, switching to an anti-androgen progestin pill is justified. This choice is made during consultation, after assessing vascular risk, family history, and hormonal evaluation.
- Mild acne and primary contraceptive need: Adepal remains an acceptable option, to be reassessed after a few months.
- Moderate acne with identified hormonal component (PCOS, hyperandrogenism): a pill with drospirenone or chlormadinone will be more appropriate.
- Severe resistant acne: dermatological treatment takes precedence over contraceptive choice, and isotretinoin may be considered independently of the pill.
Adepal is neither a bad pill nor an anti-acne treatment. The confusion between these two functions explains the disappointment of many users who expected a skin effect that levonorgestrel is not designed to produce. Asking the right question to the prescriber, distinguishing between contraceptive needs and dermatological needs, remains the starting point for coherent management.